Table 3.
Outcome | Study Group; Mean ± SD | p Value* | |
---|---|---|---|
| |||
Pre-implementation (n = 70) | Post-implementation (n = 67) | ||
No. of DTPs identified per patient | 1.0 ± 1.3 | 2.1 ± 1.4 | < 0.001 |
No. of pharmacist interventions per patient | 0.9 ± 1.3 | 1.5 ± 1.5 | 0.004 |
Clinical interventions | 0.7 ± 1.0 | 1.0 ± 1.1 | 0.12 |
Compliance interventions | 0.2 ± 0.5 | 0.6 ± 0.8 | 0.001 |
Independent t test; p values less than 0.05 were deemed significant.